IP Library Granted Patent US 7,951,553
Granted Patent B2
US 7,951,553 · App. 10/580,000 · Granted May 31, 2011

Method of assaying glycated protein

Assignee: Sekisui Medical Co., Ltd.
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,951,553
App. No.
10/580,000
Granted
May 31, 2011
Kind
B2
Abstract

The present invention provides a convenient, efficient method for assaying glycated protein, fructosyl peptide, or fructosyl amino acid which can be performed with reduced effect of fructosyl lysine compounds. The invention also provides a reagent for the assay. The invention is directed to a method for reducing the effect of a fructosyl lysine compound in an assay of fructosyl peptide or fructosyl amino acid contained in a sample, characterized by including causing an enzyme for assaying fructosyl peptide or fructosyl amino acid to act specifically on fructosyl peptide or fructosyl amino acid at a pH of 4.0 to 7.0 and measuring the product at a pH of 4.0 to 7.0; and a method for assaying glycated protein through the above method.

Claims (24)

1. A method for reducing the effect of a fructosyl lysine compound in an assay of a glycated protein-containing sample, the method comprising

treating the sample with a protease to release free fructosyl valine or fructosyl valylhistidine,

reacting a fructosyl peptide oxidase with the released fructosyl valine or fructosyl valylhistidine in the sample at a pH of 4.0 to 7.0 to produce hydrogen peroxide thereby reducing the effect of fructosyl lysine compound in the assay,

measuring the hydrogen peroxide at a pH of 4.0 to 7.0; and

correlating the measuring of the hydrogen peroxide to the presence or level of glycated protein in the sample.

2. A method according to claim 1 , wherein the glycated protein is a glycated hemoglobin.

3. The method of claim 1 or 2 , wherein the protease is obtained from:

(a) a microorganism belonging to a genus selected from the group consisting of Bacillus, Aspergillus , and Streptomyces , or

(b) a gene of the microorganism of (a) through a gene recombination technology.

4. The method of claim 1 , wherein the enzyme for assaying fructosyl valine or fructosyl valylhistidine is a fructosyl peptide oxidase.

5. A reagent for assaying glycated protein with reduced effect of a fructosyl lysine compound, which comprises:

(A) a protease;

(B) an oxidase which specifically acts on fructosyl valine or fructosyl valylhistidine at a pH of 4.0 to 7.0 to thereby produce hydrogen peroxide; and

(C) a reagent for measuring hydrogen peroxide.

6. A method for reducing the effect of a fructosyl lysine compound in an assay of fructosyl valine or fructosyl valylhistidine in a sample, the method comprising:

reacting at least one of the following (A) to (C) with free fructosyl valine or fructosyl valylhistidine at a pH of 4.0 to 7.0 after the sample has been reacted with a protease to release free fructosyl valine or fructosyl valylhistidine; and recovering a product resulting from the action of (A) to (C) in the presence or absence of fructosyl valine or fructosyl valylhistidine in the sample

(A) a fructosyl peptide oxidase,

(B) a reagent for measuring hydrogen peroxide, and

(C) a glucosone-oxidizing and decomposing enzyme.

7. A method for reducing the effect of a fructosyl lysine compound in an assay of glycated protein contained in a sample, comprising: treating the sample with a protease to thereby release fructosyl valine or fructosyl valylhistidine;

reacting a fructosyl peptide oxidase, a reagent for measuring hydrogen peroxide, or a glucosone-oxidizing and decomposing enzyme with released fructosyl valine or fructosyl valylhistidine at a pH of 4.0 to 7.0 in the presence or absence of a glycated protein in the sample.

8. The method of claim 7 , wherein the glycated protein is a glycated hemoglobin.

9. The method of claim 7 or 8 , wherein the protease is obtained from (A) a microorganism belonging to a genus selected from the group consisting of Bacillus, Aspergillus , and Streptomyces , or (B) is obtained from a gene of the microorganism of (A) through a gene recombination technology.

10. The method of claim 6 or 7 , wherein the enzyme for assaying fructosyl valine or fructosyl valylhistidine is a fructosyl peptide oxidase.

Assignments (2)
CHANGE OF NAME Recorded Mar 4, 2011
From: DAIICHI PURE CHEMICALS CO., LTD.
To: SEKISUI MEDICAL CO., LTD.
Reel/Frame 025900/0465 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 22, 2007
From: TANIGUCHI, YURIKO; EBINUMA, HIROYUKI; SAITO, KAZUNORI
To: DAIICHI PURE CHEMICALS CO., LTD.
Reel/Frame 018919/0790 →
Priority Claims (1)
JP 2003-389891 · Nov 19, 2003 · national
Continuity (1)
Related Publication 20080233605A1 · Sep 25, 2008